NLM Logo

labetuzumab MeSH Supplementary Concept Data 2023


MeSH Supplementary
labetuzumab
Unique ID
C110010
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C110010
Entry Term(s)
(131I)-MN-14
MAb hMN14
monoclonal antibody hMN-14
Pharm Action
Antineoplastic Agents, Immunological
Registry Number
EFE6X5M3UY
Previous Indexing
*ANITBODIES, MONOCLONAL (1998-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
14
Note
humanized monoclonal antibody to carcinoembryonic antigen that inhibits tumor growth; used in radioimmunotherapy
Source
Gynecol Oncol 1997 Dec;67(3):259-71
Date of Entry
1998/02/03
Revision Date
2018/09/24
labetuzumab Preferred
(131I)-MN-14 Narrower
page delivered in 0.005s